• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
First report of COVID-19 reinfection in a patient with beta thalassemia major.重型β地中海贫血患者新冠病毒再次感染的首例报告。
Clin Case Rep. 2020 Dec 19;9(2):861-865. doi: 10.1002/ccr3.3682. eCollection 2021 Feb.
2
Utility of Ct values in differentiating COVID-19 reinfection versus prolonged viral shedding in an immunocompromised patient.CT值在区分免疫功能低下患者的新冠病毒再次感染与病毒长期脱落中的作用。
BMJ Case Rep. 2021 Jul 27;14(7):e243692. doi: 10.1136/bcr-2021-243692.
3
SARS-CoV-2 and dengue virus coinfection in an adult with beta-thalassemia (trait): A case report from Bangladesh with literature review.一名成人β地中海贫血（轻型）患者感染严重急性呼吸综合征冠状病毒2和登革热病毒：来自孟加拉国的病例报告及文献综述
Heliyon. 2021 Oct;7(10):e08229. doi: 10.1016/j.heliyon.2021.e08229. Epub 2021 Oct 20.
4
[Advantages in the use of high performance liquid chromatography technique for screening hemoglobinopathies in Venezuela].[委内瑞拉使用高效液相色谱技术筛查血红蛋白病的优势]
Invest Clin. 2004 Dec;45(4):309-15.
5
Thalassemias and hemoglobinopathies in Turkey.土耳其的地中海贫血和血红蛋白病
Hemoglobin. 2014;38(5):305-7. doi: 10.3109/03630269.2014.938163. Epub 2014 Jul 17.
6
Diabetes in Patients with ß-thalassemia or other Hemoglobinopathies - Analysis from the DPV Database.β地中海贫血或其他血红蛋白病患者的糖尿病——来自糖尿病患者虚拟队列（DPV）数据库的分析
Klin Padiatr. 2016 Nov;228(6-07):307-312. doi: 10.1055/s-0042-111691. Epub 2016 Nov 15.
7
Spectrum of β-Thalassemia and Other Hemoglobinopathies in the Saurashtra Region of Gujarat, India: Analysis of a Large Population Screening Program.印度古吉拉特邦绍拉什特拉地区β-地中海贫血症和其他血红蛋白病的谱：一项大型人群筛查计划的分析。
Hemoglobin. 2022 Sep;46(5):285-289. doi: 10.1080/03630269.2022.2142608. Epub 2022 Nov 11.
8
Population Screening and Prevention Strategies for Thalassemias and other Hemoglobinopathies of Eastern India: Experience of 18,166 cases.印度东部地中海贫血及其他血红蛋白病的人群筛查与预防策略：18166例病例的经验
Hemoglobin. 2015;39(6):384-8. doi: 10.3109/03630269.2015.1068799. Epub 2015 Oct 1.
9
Clinical significance of mutational variants in beta and alpha genes in patients with hemoglobinopathies from two large Greek centers: a complex interplay between genotype and phenotype.来自两个大型希腊中心的血红蛋白病患者的β和α基因突变变异的临床意义：基因型和表型之间的复杂相互作用。
J Mol Med (Berl). 2023 Sep;101(9):1073-1082. doi: 10.1007/s00109-023-02342-3. Epub 2023 Jul 7.
10
Duration of Viral Nucleic Acid Shedding and Early Reinfection With Severe Respiratory Syndrome Coronavirus 2 in Healthcare Workers and First Responders.医护人员和急救人员中严重呼吸综合征冠状病毒 2 的病毒核酸脱落持续时间和早期再感染。
J Infect Dis. 2021 Dec 1;224(11):1873-1877. doi: 10.1093/infdis/jiab504.

引用本文的文献

1
The burden of thalassemia disorder: Past and present: The feedback of patients experience in the COVID-19 pandemic crisis.地中海贫血症的负担：过去与现在：COVID-19大流行危机中患者经历的反馈
Asian J Transfus Sci. 2025 Jan-Jun;19(1):125-129. doi: 10.4103/ajts.ajts_123_23. Epub 2024 Aug 22.
2
Epidemiological Surveillance of SARSCov2 in β-Thalassemia Patients in the Last Two Years: Reinfection Rate, Insights and Future Challenges.过去两年中β地中海贫血患者感染新冠病毒的流行病学监测：再感染率、见解与未来挑战
Mediterr J Hematol Infect Dis. 2023 Jan 1;15(1):e2023007. doi: 10.4084/MJHID.2023.007. eCollection 2023.
3
Platforms for Personalized Polytherapeutics Discovery in COVID-19.用于 COVID-19 个体化多疗法发现的平台。
J Mol Biol. 2021 May 14;433(10):166945. doi: 10.1016/j.jmb.2021.166945. Epub 2021 Mar 20.

本文引用的文献

1
COVID-19 and thalassemia beta major in splenectomized patient: Clinical case progression and literature review.脾切除患者的COVID-19与重型β地中海贫血：临床病例进展及文献综述
Clin Case Rep. 2020 Sep 12;8(12):2918-2922. doi: 10.1002/ccr3.3345. eCollection 2020 Dec.
2
Clinical characteristics of "re-positive" discharged COVID-19 pneumonia patients in Wuhan, China.中国武汉“复阳”出院新冠肺炎患者的临床特征。
Sci Rep. 2020 Oct 15;10(1):17365. doi: 10.1038/s41598-020-74284-6.
3
Bronchoalveolar lavage-based COVID-19 testing in patients with cancer.基于支气管肺泡灌洗的癌症患者 COVID-19 检测。
Hematol Oncol Stem Cell Ther. 2021 Mar;14(1):65-70. doi: 10.1016/j.hemonc.2020.09.002. Epub 2020 Oct 8.
4
A comprehensive update of ICET-A Network on COVID-19 in thalassemias: what we know and where we stand.地中海贫血患者中 COVID-19 的 ICET-A 网络全面更新：我们所知及现状
Acta Biomed. 2020 Sep 7;91(3):e2020026. doi: 10.23750/abm.v91i3.10063.
5
Prevalence, clinical manifestations, and biochemical data of type 2 diabetes mellitus versus nondiabetic symptomatic patients with COVID-19: A comparative study.2型糖尿病与非糖尿病COVID-19症状性患者的患病率、临床表现及生化数据：一项对比研究。
Acta Biomed. 2020 Sep 7;91(3):e2020010. doi: 10.23750/abm.v91i3.10214.
6
Preliminary Data on COVID-19 in Patients with Hemoglobinopathies: A Multicentre ICET-A Study.血红蛋白病患者新冠病毒病的初步数据：一项多中心ICET-A研究
Mediterr J Hematol Infect Dis. 2020 Jul 1;12(1):e2020046. doi: 10.4084/MJHID.2020.046. eCollection 2020.
7
Could Coronavirus Disease 2019 (COVID-19) Render Natural Immunity to Re-infections? A Spotlight on the Therapeutic Pipeline.2019冠状病毒病（COVID-19）能否使人获得针对再次感染的自然免疫力？聚焦治疗方案。
Front Immunol. 2020 Jun 5;11:1294. doi: 10.3389/fimmu.2020.01294. eCollection 2020.
8
COVID-19 and thalassaemia: A position statement of the Thalassaemia International Federation.COVID-19 与地中海贫血：国际地中海贫血联盟立场声明。
Eur J Haematol. 2020 Oct;105(4):378-386. doi: 10.1111/ejh.13476. Epub 2020 Jul 13.
9
Implications of SARSr-CoV 2 infection in thalassemias: Do patients fall into the "high clinical risk" category?严重急性呼吸综合征冠状病毒2感染在地中海贫血中的影响：患者是否属于“高临床风险”类别？
Acta Biomed. 2020 May 11;91(2):50-56. doi: 10.23750/abm.v91i2.9592.
10
Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period.预测 SARS-CoV-2 的传播动力学，直至大流行后期。
Science. 2020 May 22;368(6493):860-868. doi: 10.1126/science.abb5793. Epub 2020 Apr 14.

重型β地中海贫血患者新冠病毒再次感染的首例报告。

First report of COVID-19 reinfection in a patient with beta thalassemia major.

作者信息

Okar Lina, Ahmad Rita, Yassin Mohamed A

机构信息

Department of Medical Education Hamad Medical Corporation Doha Qatar.

Department of Medical Oncology, Hematology Section National Center for Cancer Care & Research Hamad Medical Corporation Doha Qatar.

出版信息

Clin Case Rep. 2020 Dec 19;9(2):861-865. doi: 10.1002/ccr3.3682. eCollection 2021 Feb.

DOI:10.1002/ccr3.3682
PMID:33598260
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7869313/
Abstract

To optimize care for patients with hemoglobinopathies, frequent screening for COVID-19 is prudent as viral kinetics in asplenic patients are unknown and differentiating prolonged viral shedding versus reinfection remains a challenge.

摘要

为优化血红蛋白病患者的护理，鉴于脾切除患者的病毒动力学尚不清楚，且区分病毒长期排出与再次感染仍是一项挑战，因此对新冠病毒病进行频繁筛查是审慎之举。